Eagle Pharmaceuticals, Inc. (EGRX)
OTCMKTS · Delayed Price · Currency is USD
3.190
0.00 (0.00%)
Aug 25, 2025, 8:00 PM EDT
Eagle Pharmaceuticals Market Cap
Eagle Pharmaceuticals has a market cap or net worth of $41.54 million as of August 27, 2025. Its market cap has decreased by -16.91% in one year.
Market Cap
41.54M
Enterprise Value
n/a
Revenue
257.55M
Ranking
n/a
PE Ratio
3.50
Stock Price
$3.19
Market Cap Chart
Since February 12, 2014, Eagle Pharmaceuticals's market cap has increased from 39.11M to 41.54M, an increase of 6.23%. That is a compound annual growth rate of 0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 41.54M | 538.00% |
| Dec 31, 2024 | 6.51M | -90.41% |
| Dec 29, 2023 | 67.92M | -82.15% |
| Dec 30, 2022 | 380.45M | -42.14% |
| Dec 31, 2021 | 657.57M | 8.37% |
| Dec 31, 2020 | 606.81M | -26.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |